OSAKA (Kyodo) The U.S. biotechnology venture MediciNova debuted Tuesday on the Osaka Securities Exchange’s Hercules market, becoming the first foreign company to list on the bourse for startups.

MediciNova began trading at 405 yen, up 5 yen from its initial public offering price.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.